Regency Capital Management Inc.\De Vectiv Bio Holding Ag Transaction History

Regency Capital Management Inc.\De

  • $165 Million
  • Q3 2024

A detailed history of Regency Capital Management Inc.\De transactions in Vectiv Bio Holding Ag stock. As of the latest transaction made, Regency Capital Management Inc.\De holds 510,000 shares of VECT stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
510,000
Previous 510,000 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024
BUY
N/A
480,000 Added 1600.0%
510,000 $0
Q2 2023

Aug 01, 2023
SELL
$8.29 - $16.97 $66,320 - $135,760
-8,000 Reduced 21.05%
30,000 $506,000
Q1 2023

May 08, 2023
BUY
$7.34 - $9.15 $278,920 - $347,700
38,000 New
38,000 $323,000

Others Institutions Holding VECT

# of Institutions
1
Shares Held
510K
Call Options Held
0
Put Options Held
0
View Full List

About VectivBio Holding AG

VECT Quotes by TradingView
  • Ticker VECT
  • Exchange NASDAQ
  • Description
  • VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...
More about VECT
Track This Portfolio

Track Regency Capital Management Inc.\De Portfolio

Follow Regency Capital Management Inc.\De and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regency Capital Management Inc.\De, based on Form 13F filings with the SEC.

News

Stay updated on Regency Capital Management Inc.\De with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email